Goulet, D.R.; Chatterjee, S.; Lee, W.-P.; Waight, A.B.; Zhu, Y.; Mak, A.N.-S.
Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability. Antibodies 2022, 11, 6.
https://doi.org/10.3390/antib11010006
AMA Style
Goulet DR, Chatterjee S, Lee W-P, Waight AB, Zhu Y, Mak AN-S.
Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability. Antibodies. 2022; 11(1):6.
https://doi.org/10.3390/antib11010006
Chicago/Turabian Style
Goulet, Dennis R., Soumili Chatterjee, Wai-Ping Lee, Andrew B. Waight, Yi Zhu, and Amanda Nga-Sze Mak.
2022. "Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability" Antibodies 11, no. 1: 6.
https://doi.org/10.3390/antib11010006
APA Style
Goulet, D. R., Chatterjee, S., Lee, W.-P., Waight, A. B., Zhu, Y., & Mak, A. N.-S.
(2022). Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability. Antibodies, 11(1), 6.
https://doi.org/10.3390/antib11010006